Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to LANTUS in Adult Patients With Type 2 Diabetes Mellitus: The ELEMENT 5 Study

Next Previous
Search
Trial Profile

A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to LANTUS in Adult Patients With Type 2 Diabetes Mellitus: The ELEMENT 5 Study

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 13 Nov 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin glargine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms ELEMENT 5
  • Sponsors Eli Lilly and Company

    • Most Recent Events

    • 22 May 2019 Results of subgroup analysis from India and east Asia published in the Clinical Drug Investigation.
    • 01 Feb 2019 Results compared the efficacy and safety of similar U-100 insulin glargine products, namely, Lilly insulin glargine (LY IGlar; Basaglar) and the reference insulin glargine product , published in the Diabetes Therapy.
    • 05 Oct 2018 Results of an exploratory analyses from ELEMENT-2 and ELEMENT-5 presented at the 54th Annual Meeting of the European Association for the Study of Diabetes

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top